l-Arginine depletion by arginase reduces nitric oxide production in endotoxic shock: an electron paramagnetic resonance study  by Bune, A.J. et al.
FEBS 15567 FEBS Letters 366 (1995) 127-130 
L-Arginine depletion by arginase reduces nitric oxide production 
in endotoxic shock: 
an electron paramagnetic resonance study 
A.J. Bune a, J.K. Shergill b, R. Cammack b, H.T. Cook a,* 
aDepartment of Histopathology, St.Marys Hospital Medical School, Imperial College of Science, Technology and Medicine, 
Norfolk Place, London W2 IPG, UK 
bCentre for the Study of Metals in Biology and Medicine, Division of Life Sciences, King's College, University of London, 
Campden Hill Road, London W8 7AH, UK 
Received 29 April 1995 
Abstract Nitric oxide (NO) synthesis was measured in the liver, 
lung, spleen and kidney of Iipopolysaccharide-treated male rats 
using the nitric oxide spin trap, iron (ll)-dlethyldithiocarbamate 
(FeDETC2). Nitric oxide formation in vlvo was determined by the 
Increase in intensity of the characteristic triplet hyperflne EPR 
spectrum of [NO-FeDETC,]. Intravenous bovine liver arginase, 
nt a dose which completely depleted circniating arginlne, signifi- 
cantly reduced the formation of nitric oxide in these tissues. The 
general decrease in NO levels was confirmed by the decrease in 
plasma nitrite levels. These results directly demonstrate hat NO 
formation in endotoxic shock depends on extracellular arginine; 
depletion of plasma rginine may be a useful therapeutic strategy. 
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1. Introduction 
Nitric oxide is a highly reactive free radical which is syn- 
thesised from L-arginine by a family of nitric oxide synthases 
[1,2]. The calcium-dependent, or constitutive NOS, as found in 
endothelium and neurones, rapidly synthesizes small amounts 
of nitric oxide in response to increases in intracellular calcium, 
whereas the calcium independent NOS, also known as induci- 
ble NOS (iNOS) is under transcriptional control [3-5]. Synthe- 
sis of iNOS is stimulated by cytokines or endotoxin and, once 
the enzyme is formed, nitric oxide is produced in large amounts 
for several hours independently of intracellular calcium levels. 
We have previously demonstrated by immunohistochemistry 
the widespread istribution of inducible NOS in rats given 
lipopolysaccharide [6]. 
NO produced by the inducible enzyme is a major mediator 
of macrophage cytotoxicity [7-9] and has been implicated as a 
mediator in septic shock [10-12] and inflammation. The stable 
end products of NO are NO~ and NO~ and these have previously 
been employed as a measure of NO production [13]. Demon- 
stration of the relative importance ofconstitutive and inducible 
NOS in pathological conditions has been hampered by the lack 
of specific inhibitors of the individual isoforms of NOS. Thus 
*Corresponding author. Fax: (44) (171) 724 7349. 
Abbreviations: NOS, nitric oxide synthase; L.NMMA, NG-mono - 
methyl-L-arginine; LPS, lipopolysaccharide; DETC, diethyldithiocar- 
bamate; EPR, electron paramagnetic resonance. 
L-arginine analogues uch as N°-monomethyl.L-arginine (L- 
NMMA) inhibit both constitutive and inducible enzymes and 
may lead to changes in blood pressure or blood flow which 
could confound interpretation of in rive studies designed to 
elucidate the role of inducible NOS. The inducible enzyme is 
critically dependent on an extracellular supply of substrate L-
arginine [14-16], and in vitro depletion of L-arginine in the 
medium inhibits macrophage cytotoxicity [16]. The apparent 
Michaelis constant for L-arginine in NO synthesis by iNOS in 
murine macrophages i  73/zM [14] and plasma levels of L- 
arginine are around 225/~M. Griffith et al. [17] have provided 
evidence that it is possible to decrease NO synthesis in the 
guinea pig by using arginase to deplete plasma rginine. In the 
present study, we have investigated the effect of arginase on 
induced NO production by electron paramagnetic resonance 
(EPR) spectroscopy and the spin-trap iron(II) diethyldithiocar- 
bamate (FeDETC2), recently developed by Vanin et al., and 
shown to specifically trap NO formed in animal tissues in rive 
[18]. NO generated in rats given LPS alone, LPS/L-NMMA or 
LPS/arginase was directly measured from the NO-FeDETC2 
EPR signal observed from tissue homogenates. 
2. Materials and methods 
2.1. Materials 
L-NMMA was a gift from Dr. S. Moncada (Wellcome Research 
Laboratories, Beckenham, Kent). Rabbit anti-iNOS antiserum [19] was 
a gift from Dr. V. Riveros-Moreno (Wellcome Research Laboratories) 
and the streptavidin-biotin peroxidase ystem from Dakopatts (High 
Wycombe, Bucks, UK). The anti-macrophage monoclonal EDI was 
obtained from Serotec (Kidlington, Oxfordshire). 
Pseudomonas oleovorans was from National Collection of Type Cul- 
tures (Colindale, London, UK). LPS Escherichia coil serotype 0127:B8, 
bovine liver arginase and all other eagents used were obtained from 
Sigma Chemical Co. (Peele, Dorset). 
2.2. LPS administration 
Experiments were carried out on inbred male Lewis rats weighing 
170-270 g, with all injections given in no~.,~lal s line. LPS (4 mg/kg).was 
administered intraperitoneaily (n = 28). Control rats were gwen 
FeDETC2 only (n = 2). Thirty minutes prior to sacrifice all rats were 
given DETC (500 rag/kg) intraperitoneally nd FeSO4 (50 mg/kg), so- 
dium citrate (250 mg/kg) subcutaneously. 4 h after LPS administration, 
some rats were given arginase i.e., (2,500 U/rat, n = 1 i), or L-NMMA, 
i.p. (50 mg/kg, n= 7) or equivalent amounts of saline. 
5 h after LPS, the animals were killed and the relevant tissues frozen 
immediately in liquid nitrogen. Sections taken were fixed for 48 h in 
buffered formal saline for histology and immunohistochemistry, 
Plasma was collected for NO.~/NO[ and arginine l vels. Homogenized 
tissue samples were analysed for total protein by the modified Lowry 
method [20], by absorbance at 660 nm. 
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Paraffin sections were dewaxed, microwaved in citrate buffer and 
incubated with the iNOS antibody (l: 2,000) at 4°C with a biotinylated 
polyclonal swine anti-rabbit secondary antibody [6]. Macrophages were 
labelled with the mouse monoclonal antibody EDI (1:500), with a 
biotinylated rabbit anti-mouse secondary antibody. Both were detected 
with streptavidin/biotin peroxidase complex with diaminobenzidine as
chromagen and haematoxylin counterstain. 
2.4. Plasma nitrite/nitrate and arginine analysis 
Blood was anticoagulated with heparin, plasma was separated and 
frozen for analysis. The pl~_xma was treated with NaOH (0.5 M), and 
the protein precipitated with ZnSO4 (10~). Nitrate was reduced to 
nitrite with nitrate reductase from Pseudomonas oleovorans and assayed 
using the Griess Reaction, with the lower limit of detection being 7.5 
#M [6]. Arginine levels in plasma were determined by HPLC as de- 
scribed previously [21], 
2,5, £P,q apt~troscopy 
Tissue samples removed from the rat immediately after killing were 
homogenized in an equal weight of 0.2 M HEPES buffer, pH 7.4, placed 
in quartz EPR tubes (ca. 3,4 mm i.d.), and frozen in liquid nitrogen. 
X.band EPR spectra were recorded on a Bruker ESP 300 spectrometer 
fitted with an Oxford Instruments ESR 900 liquid helium flow cryostat. 
Spectral baselines were corrected by subtraction of a cavity/water spec- 
trum recorded under identical conditions. The concentration of NO- 
FeDETC: was estimated by careful measurement of the peak 
(g = 2.047)-to-baseline h ight, after normalisation of the data. This 
provides a measure of the amount of NO available for trapping by 
FeDETC2. 
3. Results 
The plasma L-arginine concentration in normal Lewis rats 
was estimated to be 225 4- 18/aM (n = 12). Preliminary experi- 
ments showed that a single dose of 2,500 units of arginase 
reduced plasma arginine to undeteetable l vels for 4 h and that 
at 8 h plasma arginine was 17 4- 1/aM. This dose was chosen 
for farther experiments. LPS treatment alone redt,.~d plasma 
arginine levels to less than a quarter (50 + 9.3/aM) and arginase 
administration after LPS resulted in undetectable l vels of 
arginine one hour later. 
NO; INO]  levels were undeteetable in control animals 
but increased to 293/aM 4. 36 after LPS (Fig. 1). This rise in 
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Fig, I, Plasma NO]INO; levels in endotoxin-treated rats with or with- 
out arginase or L-NMMA. Results expressed as mean +_ S.E.M. (n = 
6-10 where P < 0.01 using an unpaired Student's t-test). 
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Fig. 2. X-band EPR spectra from endotoxin.treated rats. Spleen homo- 
senate from rats treated with DETC and Fe-eitrate alone 30 min before 
sacrifice (a), and representative spectra of (b) spleen, (c) kidney and 
(d) liver homogenates from rats administered LPS (5 h before death) 
and DETC and Fe.citrate (30 rain prior to death); (e) liver homogenate 
from an untreated rat. Measurement conditions were: temperature, 
15 K; microwave power, 20 roW; microwave frequency, 9.34 GHz; 
modulation amplitude, (a-d) 0.49, (e) 0.98 mT; time constant, 0.08 s; 
sweep rate (a-d) 1.19, (e) 2.38 mTIs. The spectra re an average of 2 
scans, and have been normalised to aPow direct comparison. The g- 
factors are indicated in the figure as: g -" 2.08, D; g = 2.035, o; g = 2.02, 
^; g = 1.93, A; g = 1.88, *). 
NO;/NO~ was significantly attenuated by arginase (I 23.7 + 15 
/aM) or by L-NMMA (85 + 14/aM). 
Nitric oxide was detected by EPR using the spin trap 
FeDETC2 [18]. Fig. 2a shows the g = 2 region of the EPR 
spectrum of spleen removed from a rat treated with FeDETC2 
only. At 15 K, the tissue exhibited an intense quartet signal at 
A.J. Bune et al./FEBS Letters 366 (1995) 127-130 129 
-321.6, 326.0, 331.0, 336.1 mT (a~-4.9 mT), characteristic of
DETC complexed with endogenous copper [18]; this signal was 
detected at temperatures upto 100 K. A weaker signal to higher 
field at g-~ 1.94 was also present in the spectrum and assigned 
to reduced iron-sulphur proteins. Endotoxin administration to
the rat resulted in the detection of a prominent new signal in 
the g = 2 region, from spleen, liver, kidney and lung (Fig. 2b--d). 
The EPR spectrum now displayed the characteristic three-line 
s~-ctrum of NO-FeDETC2 similar to that demonstrated previ- 
¢,usly by other workers [18,22], at gz = 2.02, gyx = 2.035, with 
'~t riplet hyperfine structure (a = 1.3 mT) at gyx, due to the 
interaction of the unpaired electron on the ~4N nucleus of NO 
complexing with free FeDETC2 (see Fig. 2). The NO- 
FeDETC2 signal is readily distinguished from background sig- 
nals due to endogenously-reduced iron-sulphur clusters. The 
EPR signal of free FeDETC2 is no longer visible. This could 
be due to overlap by the more intense signal from the mononi- 
trosyl complex, or a more likely explanation may be that all of 
the spin-trap has converted to NO-FeDETC2, due to excess 
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Fig. 3. Effects of arginase and L-NMMA on the endotoxin-stimulated 
NO-FeDETC2 EPR signal (indicated by the arrows) from the spleen of 
LPS-treated rats. Animals were injected with LPS five hours before 
sacrifice, and either (a) saline, (b) arginase or (c) L-NMMA 4 h after 
LPS. Protein concentration, (a)114, (b) 171 and (c) 215 mg/g wet tissue. 
Measurement conditions were as for Fig. 2b. 
amounts of NO being formed by iNOS. The latter suggestion 
is supported by the observation of a broad feature at g~2.08 
which is indicative of haem-nitrosyl complex formation [23]. 
Kidney and liver from rats treated with endotoxin displayed 
similar spectra (Fig. 2c--d), though with more intense signals at 
g=1.93 and g=1.88 from iron-sulphur clusters. Both the 
g-value and lineshape of these signals are diagnostic of the 
mitochondrial iron-sulphur proteins, such as NADH dehydro- 
genase and succinate dehydrogenase (Complexes I and II of the 
respiratory chain, respectively). Furthermore, there was no ev- 
idence for NO formation in the homogenate of a control ani- 
mal, although particularly prominent signals were observed 
from these iron-sulphur proteins (Fig. 2e). 
Upon administration of arginase 4 h after LPS a marked 
decrease was observed in the endotoxin-stimulated NO- 
FeDETC2 signal, as indicated by the arrows in Fig. 3 (of. spec- 
tra a and b). This decrease was even more noticeable in the 
spleen from rats administered with the inhibitory analogue, 
L-NMMA (Fig. 3c). In the presence of L-NMMA the amplitude 
of the NO-FeDETC2 signal was so attenuated that the EPR 
signal from free FeDETC2 could now be resolved (of. spectrum 
2a with 3c). Similar results were obtained with rat lung, liver 
and kidney (data not shown). The effects of arginase and L- 
NMMA on the intensity of the mononitrosyi complex signal 
are summarised in Fig. 4. 
Endotoxin treatment caused an influx of macrophages into 
all tissues examined and macrophage numbers were increased 
2-fold over normal tissues. No difference in macrophage influx 
was apparent between LPS, LPS/arginase, and LPS/L-NMMA 
treated tissues. 
4. Discussion 
The purpose of these experiments was to study the effect of 
depletion of circulating L-arginine on the synthesis of NO in 
vivo. We used a model of endotoxin administration i rats 
which has previously been shown to lead to synthesis of the 
inducible isoform of NOS and a marked increase in NO synthe- 
sis in multiple organs [6,10,12]. We have used two separate 
measures of NO synthesis. First, to obtain an indirect measure 
of whole body NO synthesis, we measured the accumulation of
nitrite and nitrate, the stable end-products of NO, in the 
plasma. Secondly, in order to detc:~nine the extent of NO syn- 
thesis in individual organs we used EPR spectroscopy tomeas- 
ure the NO adduct formed with the spin trap FeDETC2, a 
method which has previously been employed to measure organ- 
specific NO synthesis nmice [18] and rats [22,24]. The insoluble 
complex remains in the tissues, and the size of the EPR signal 
obtained in the presence of FeDETC2 is related to the amount 
of nitric oxide synthesized during the 30-min period before the 
animals were killed. Using these methods we have demon- 
strated that LPS led to a marked increase in circulating nitrite 
and nitrate with NO synthesized in liver, kidney, lung and 
spleen fro,'~ 4.5 to 5 h after LPS administration. As expected, 
the arginine analogue L-NMMA given at 4 h reduced circulat- 
ing nitrite and nitrate and markedly reduced the synthesis of 
NO in all four organs. 
In order to deplete L-arginine in the plasma we gave rats an 
intravenous bolus injection of bovine liver arginase which catal- 
yses the conversion of L-arginine to L.ornithine and urea. Argi- 
nase is w~ll tolerated and indeed has previously been given for 
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Fill, 4. Effect of arginase/L-NMMA on the EPR signal intensities of the [NO-FeDETCd complex in LPS treated tissues. Results expressed as 
mean :!: S.E.M., where *P < 0.01, **P < 0.05, using unpaired Student's t-test. 
days or weeks in experiments examining its possible ffect on 
turnouts [25,26]. Importantly, there was no effect on systemic 
blood pressure (results not shown) implying that synthesis of 
NO by the vascular calcium-dependent nitric oxide synthase 
was not inhibited. We therefore gave arginase 4 h after LPS and 
studied NO synthesis by using FeDETC2. Arginase treatment 
after LPS reduced plasma arginine to undetectable levels, al- 
though interestingly LPS itself led to a marked reduction in 
L-arginine at 5 h, possibly by consumption to generate NO. In 
kidney, liver, lung and spleen, arginase significantly reduced the 
synthesis of NO as detected by EPR although the effect was not 
as large as that observed with L-NMMA, 
It has been suggested that NO may act to down-regulate 
expression of vascular adhesion molecules and thereby prevent 
leukocyte infiltration into tissues, However, we found no effect 
of arginase or I.-NMMA on the LPS-induced increase in tissue 
macrophage numbers. 
Our results demonstrate hat intracellular stores of l.-argin- 
inn are insufficient to sustain the massive rise in NO synthesis 
which occurs after endotoxin ~dministration a d that this syn- 
the~ depends partly on the supply of extracellular L-arginine. 
This suggem that measures to lower the availability of L-argin- 
inn may be useful for exploring the role of NO synthesis by 
iNOS at sites of localized inflammation, without he drawbacks 
associated with inhibition of systemic NO synthesis by the 
calcium-dependent isoforms of NOS. 
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